Global Medicated Skin Care Products Market Research Report 2022

Medicated skin care products help in overcoming various skin related problems by wounding skin healings with the help of its anti-inflammatory and other useful medical properties. Medicated skin care products are also used to treat various skin related issues such as psoriasis, eczema, dry skin, and dermatitis. They come in various forms including cleansers, face and body moisturizers, hand & foot creams, scrubs, lip care, and hand sanitizers, among others. Medicated skin care products calm the irritated and inflamed skin while restoring weakened skin with essential natural and artificial ingredients. Medicated skin care products are infused with various ingredients, which are vital for the process of skin healing. For instance, Madecassoside is an active skin care ingredient derived from the plant Centella asiatica. Centella asiatica is a medicinal plant that has been used in Ayurveda medicine in India for several years. Madecassoside has various anti-aging as well as skin healing properties.
Due to the COVID-19 pandemic, the global Medicated Skin Care Products market size is estimated to be worth US$ 7163.7 million in 2021 and is forecast to a readjusted size of US$ 8157.5 million by 2028 with a CAGR of 1.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Medicated Skin Care Products market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Medicated Skin Care Products landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Natural accounting for % of the Medicated Skin Care Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Male segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Medicated Skin Care Products include Bayer, Beiersdorf, Pfizer, Johnson & Johnson, Kao Corporation, Baxter Laboratories, Advanced Dermatology, Anacor Pharmaceuticals and SkinMedica, etc. In terms of revenue, the global 3 largest players have a % market share of Medicated Skin Care Products in 2021.
This report focuses on Medicated Skin Care Products volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Medicated Skin Care Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Medicated Skin Care Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Natural
Synthetic
Segment by Application
Male
Female
Kids
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer
Beiersdorf
Pfizer
Johnson & Johnson
Kao Corporation
Baxter Laboratories
Advanced Dermatology
Anacor Pharmaceuticals
SkinMedica
Unilever
Taisho Pharmaceuticals
Otsuka Pharmaceutical
Merz North America